The effect of acupuncture versus cognitive behavior therapy on insomnia in cancer survivors: A randomized clinical trial.

Authors

null

Jun J. Mao

Memorial Sloan Kettering Cancer Center, New York, NY

Jun J. Mao , Sharon Xie , Katherine Duhamel , Ting Bao , Philip W. Kantoff , Qing Susan Li , Frances Barg , Sarah Song , Philip Gehrman , Sheila N. Garland

Organizations

Memorial Sloan Kettering Cancer Center, New York, NY, University of Pennsylvania, Philadelphia, PA, Memorial Sloan Kettering Cancer Center, New York, NY, US, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, Memorial University of Newfoundland, St. John's, NF, Canada

Research Funding

Other

Background: Insomnia is a common and debilitating disorder experienced by up to 60% of cancer survivors. We evaluated the effectiveness of acupuncture versus cognitive behavior therapy for insomnia (CBT-I). Methods: We conducted a randomized clinical trial of acupuncture vs. CBT-I among 160 post-treatment cancer survivors with clinically diagnosed insomnia disorder. Acupuncture involved stimulating body points with needles. CBT-I included sleep restriction, stimulus control, cognitive restructuring, relaxation training, and education. The intervention duration was eight weeks (primary end point) with a follow up assessment at 20 weeks. Insomnia severity, measured by the Insomnia Severity Index, was the primary outcome. Results: The mean age of participants was 61.5 years, 57% (n = 91) were women, and 29.4% (n = 47) were non-white. At the end of treatment, acupuncture reduced insomnia severity by 8.3 points (95% CI 7.3-9.4), compared to 10.9 points (95% CI 9.8-12.0) for CBT-I, with CBT-I being the more effective treatment overall (2.6, 95% CI 1.1 – 4.1, P = 0.0007). Patients with mild insomnia were significantly more likely to respond to CBT-I than acupuncture (85% vs. 18%, p < 0.0001); however, patients with moderate to severe insomnia had similar response rates to CBT-I and acupuncture (75% vs. 66%, p = 0.26). Both groups had few mild adverse events and maintained improvements up to 20 weeks. Both groups also had similar improvement in quality of life in physical health (p = 0.46) and mental health (p = 0.44) during the study. Conclusions: While both acupuncture and CBT-I resulted in clinically meaningful and durable effects among cancer survivors with insomnia, CBT-I was more effective, especially among patients with mild insomnia symptoms. Patients and oncology clinicians can use these findings to inform their choice of insomnia treatment. Clinical trial information: NCT02356575

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2018 ASCO Annual Meeting

Session Type

Oral Abstract Session

Session Title

Patient and Survivor Care

Track

Patient and Survivor Care

Sub Track

Palliative Care and Symptom Management

Clinical Trial Registration Number

NCT02356575

Citation

J Clin Oncol 36, 2018 (suppl; abstr 10001)

DOI

10.1200/JCO.2018.36.15_suppl.10001

Abstract #

10001

Abstract Disclosures

Similar Abstracts

First Author: Karen Michelle Mustian

Abstract

2018 Cancer Survivorship Symposium

Behavioral treatment of insomnia in cancer survivors: Early results of a stepped-care trial.

First Author: Christopher J. Recklitis